<i>Thermoactinomyces candidus</i> Precipitating Antibodies, IgG
Thermoactinomyces candidus Precipitating Antibodies, IgG
    
Number
660035
CPT
86602
Related Information
  • Hypersensitivity Pneumonitis Profile
  • Synonyms
    Forced Air System Disease ; Hypersensitivity Pneumonitis
    Specimen
    Serum
    Volume
    0.2 mL
    Container
    One 10 mL red-top tube or one 10 mL gel-barrier tube
    Storage Instructions
    Refrigerate
    Causes for Rejection
    Excessive hemolysis
    Reference Interval
    Normal: negative
    Use
    Confirm the presence of precipitating antibodies to Thermoactinomyces candidus
    Limitations
    A positive test does not establish the diagnosis of hypersensitivity pneumonitis, nor does the absence of precipitins eliminate the diagnosis.
    Methodology
    Double diffusion (Ouchterlony)
    Additional Information
    Hypersensitivity pneumonitis (HP), also referred to as extrinsic allergic alveolitis (EAA), is an inflammatory lung disease resulting from the inhalation and subsequent sensitization to a wide variety of inhaled organic dusts.1,2,3,4,5 HP is not mediated by IgE. It is associated with progressive pulmonary disability, irreversible lung damage, and mortality in some occupational settings.1,2,3,4,5 Patients often present with intermittent chills, fever, cough, and shortness of breath that begin 4-8 hours after exposure to the offending dust.

    Thermophilic actinomycetes can be found in soil, foods, fresh water, and other natural sources.5 These organisms grow well in decaying organic materials at temperatures often attained during decomposition.5 Exposure to Thermoactinomyces candidus can result from contact with a contaminated heating system causing a condition referred to as forced air system disease.3

    No single laboratory test is diagnostic for hypersensitivity pneumonitis.1,2,3,4,5 Diagnosis is based on a complete environmental history supported by result of chest x-ray, spirometry, and in vitro immunologic tests.1,2,3,4,5 Identification of the causative agent is important to allow avoidance of exposure.2,5 Double diffusion (Ouchterlony) assays are typically used to determine antigen-specific IgG antibodies.5 The appearance of precipitin arcs confirms the presence of precipitating antibodies to specific antigens. These antibodies may also be present in individuals not afflicted with HP.2,3,5 The presence of antibodies to the offending dust or antigen confirms exposure but is not diagnostic of HP. However, upon repeated or prolonged exposures, high levels of precipitating IgG antibodies are typically observed.

    Footnotes
    1. Richerson HB, Bernstein IL, Fink JN, et al, “Guidelines for the Clinical Evaluation of Hypersensitivity Pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis,” J Allergy Clin Immunol, 1989, 84(5 Pt 2):839-44.
    2. Patel AM, Ryu JH, and Reed CE, “Hypersensitivity Pneumonitis: Current Concepts and Future Questions,” J Allergy Clin Immunol, 2001, 108(5):661-70.
    3. Kurup VP and Fink JN, “Immunological Tests for Evaluation of Hypersensitivity Pneumonitis an Allergic Bronchopulmonary Aspergillosis,” Manual of Clinical Immunology, 6th ed, Rose NR, Hamilton RG, and Detrick B, eds, Washington, DC: ASM Press, 2002, 910-9.
    4. Zacharisen MC and Fink JN, “Hypersensitivity Pneumonitis,” Patterson's Allergic Disease, 6th ed, Grammar LC and Greenberger PA, eds, Philadelphia, PA: Lippincott Williams and Wilkins, 2002, 515-28.
    5. Greer Technical Bulletin #47, Hypersensitivity Pneumonitis/Extrinsic Allergic Alveolitis
    References

    Yi ES, “Hypersensitivity Pneumonitis,” Crit Rev Clin Lab Sci, 2002, 39(6):581-629.


    Copyright © 2007 by Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved